George Poste is Chief Executive Officer of Health Technology Networks, a healthcare consultancy group, and Chief Scientist at the Complex Adaptive Systems Initiative (CASI) at Arizona State University. This programme integrates research in genomics, synthetic biology and high-performance computing to study the altered regulation of molecular networks in human diseases.
Previously, George served as Chief Science and Technology Officer and President, R&D, of SmithKline Beecham (now GlaxoSmithKline). In 2004, he was named ‘R&D Scientist of the Year’ by R&D Magazine and in 2006 he received the Einstein Technology Award from the Global Business Leadership Council. In 2009, he received the Scrip Lifetime Achievement Award, voted by the leadership of the global pharmaceutical industry.
George is a member of the Council for Foreign Relations, the Institute of Medicine Board on Global Health, and several US government advisory committees on defence, national security and healthcare.
Chief Executive Officer, Health Technology Networks
Chair of Scientific Advisory Board, A. Alfred Taubman Medical Research Institute, University Of Michigan
Member of Board of Directors, Caris Life Sciences
Member of Board of Directors, Exelixis
Member, Forum on Microbial Threats, Institute of Medicine
Member of Scientific Advisory Board, Haplogen GmbH
Member of Board of Directors, Monsanto Company
Chair of Scientific Advisory Board, Synthetic Genomics
Chief Scientist and Regents’ Professor and Del E. Webb Chair in Health Innovation, Complex Adaptive Systems Initiative, Arizona State University
Interest and expertise
- Microbiology, immunology and developmental biology
- General microbiology (incl bacteriology and virology)
- Health and human sciences
- Clinical pathology, Molecular medicine
- Biochemistry and molecular cell biology
cancer metastasis, cancer clonal evolution, drug delivery, vaccine design, molecular diagnostics, biological warfare, science policy